Skip to Content

Triton Group(Triley Bidco)/Clinigen

M/21/078

Completed

Transaction details

The proposed acquisition by Triley Bidco Limited, which is indirectly controlled by funds managed or advised by Triton Fund V L.P, of sole control of Clinigen Group plc has been cleared by the Competition and Consumer Protection Commission.
Case details
  • Notification date:23 December 2021
  • Publication date:23 December 2021
  • Economic sector:Professional, scientific & technical activities - N
  • Economic sub-sector:Scientific research & development - N.72
  • Simplified merger:Yes
  • Outcome:Cleared
Documents
Timetable

Phase One

  • Thursday, 23 December, 2021 Notification received
  • Wednesday, 5 January, 2022 Third party submission deadline
  • Tuesday, 11 January, 2022 Determination issued
Parties Involved

Triton Group

Triton Group is a privately-held investment firm that manages a number of independent investment funds and companies.

 

Clinigen Group plc

Clinigen is a global pharmaceutical services and products company focused on providing ethical access to medicines.

Contacts
View all mergers